rofecoxib has been researched along with Mesothelioma in 2 studies
Mesothelioma: A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoppoloni, D | 1 |
| Canino, C | 1 |
| Cardillo, I | 1 |
| Verdina, A | 1 |
| Baldi, A | 1 |
| Sacchi, A | 1 |
| Galati, R | 1 |
| DeLong, P | 1 |
| Tanaka, T | 1 |
| Kruklitis, R | 1 |
| Henry, AC | 1 |
| Kapoor, V | 1 |
| Kaiser, LR | 1 |
| Sterman, DH | 1 |
| Albelda, SM | 1 |
2 other studies available for rofecoxib and Mesothelioma
| Article | Year |
|---|---|
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-D | 2010 |
Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy.
Topics: Adenoviridae; Animals; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Cyclooxygenase 2; Cycl | 2003 |